<DOC>
	<DOCNO>NCT01052896</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness gabapentin symptom control patient define functional dyspepsia refractory conventional proton pump inhibitor therapy compare effect placebo .</brief_summary>
	<brief_title>Gabapentin Functional Dyspepsia Refractory Proton Pump Inhibition</brief_title>
	<detailed_description>In pilot study hypothesize patient gabapentin increase adequacy dyspepsia symptom control two month well improvement dyspepsia symptom index score surrogate quality life measure , compare placebo . While functional dyspepsia divide four subtypes study group four 'functional dyspepsia ' treat one . Proton pump inhibition may benefit epigastric pain burn typically post-prandial fullness early satiety . ( Tack et al ) . Those patient symptoms refractory proton pump inhibition might benefit medication modifies visceral hypersensitivity gabapentin . It possible modify pain syndrome decrease need follow-up appointment improve patient quality life .</detailed_description>
	<mesh_term>Dyspepsia</mesh_term>
	<mesh_term>Gastritis</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>Patients include study adult ( age &gt; 18 year ) define functional dyspepsia per ROME III criterion negative EGD proton pump inhibitor therapy yet still sense inadequate symptom control . Patients exclude woman childbearing age refuse baseline pregnancy test and/or refuse prevent pregnancy trial period . Exclusion criterion also include anyone history adverse effect allergy gabapentin . Finally , patient undergoing hemodialysis history creatinine chronically great 1.5 exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Dyspepsia</keyword>
	<keyword>Functional</keyword>
</DOC>